Share Price and Basic Stock Data
Last Updated: November 28, 2025, 11:13 am
| PEG Ratio | 5.88 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Fundviser Capital (India) Ltd operates within the Finance & Investments sector, with a current market capitalization of ₹124 Cr and a share price of ₹209. The company’s revenue has shown a fluctuating trend over the recent quarters. In the latest reported quarter, September 2023, sales amounted to ₹0.62 Cr, a significant increase from ₹0.02 Cr in June 2023. However, the company faced a downturn in March 2023, with revenue dropping to -₹0.03 Cr. Annual sales figures also reflect this inconsistency, with a reported ₹0.97 Cr for the fiscal year ending March 2024 and ₹2.17 Cr for March 2025. The trailing twelve months (TTM) revenue stood at ₹2.30 Cr, indicating a recovery from previous lows. Overall, while there is a notable recovery in revenue, the volatility raises questions regarding the sustainability of this growth in a competitive market.
Profitability and Efficiency Metrics
Fundviser Capital has reported varied profitability metrics, with an operating profit margin (OPM) of -100.00% as of the latest quarter, reflecting significant operational challenges. However, in September 2023, the OPM improved dramatically to 91.94%, indicating a potential turnaround in operational efficiency. The net profit for the same quarter was ₹0.50 Cr, leading to an earnings per share (EPS) of ₹1.36. Despite this, the company’s return on equity (ROE) stood at a low 2.88%, and return on capital employed (ROCE) was 3.76%, both signaling underperformance relative to industry benchmarks. The interest coverage ratio (ICR) was reported at an impressive 24.74x, suggesting that the company is well-positioned to meet its interest obligations. Nonetheless, the overall profitability indicators remain mixed, highlighting a need for sustained operational improvements.
Balance Sheet Strength and Financial Ratios
The balance sheet of Fundviser Capital reflects a cautious financial strategy, with no reported borrowings or reserves, which is atypical for a finance company. The price-to-book value (P/BV) ratio is noted at 4.04x, suggesting that the market values the company’s equity at a premium compared to its book value. Financial ratios indicate a current ratio of 1.33, signaling adequate liquidity to meet short-term obligations. The company’s total debt-to-equity ratio stands at 0.39, indicating a low reliance on debt financing, which may reduce financial risk. However, the working capital days have increased significantly to 518.06 days for March 2025, suggesting inefficiencies in managing working capital. The firm’s financial health appears stable but could benefit from better operational efficiencies and an increased focus on revenue generation.
Shareholding Pattern and Investor Confidence
Fundviser Capital’s shareholding structure shows a substantial promoter holding of 66.36%, which may indicate strong confidence from the company’s founders in its future prospects. The public shareholding has declined to 33.22%, while domestic institutional investors (DIIs) are marginally present at 0.42%. The number of shareholders has reduced to 3,736, reflecting a potential consolidation among investors. The promoter holding has seen a steady increase from 53.12% in March 2023 to the current level, which may signal confidence in the company’s strategic direction. However, the low presence of institutional investors could be a concern, as it may limit the stock’s liquidity and attractiveness to larger investment funds. This concentrated ownership structure could be a double-edged sword, enhancing stability while potentially limiting broader market appeal.
Outlook, Risks, and Final Insight
The outlook for Fundviser Capital appears cautiously optimistic, given the recent improvements in revenue and profitability metrics. However, the company faces several risks, including operational inefficiencies that could hinder sustained profitability and increased competition in the finance sector. The significant volatility in quarterly sales and the low return ratios highlight the need for strategic initiatives to enhance operational performance. Additionally, the absence of borrowings could limit growth opportunities, as leveraging could provide the necessary capital for expansion. Moving forward, the company must focus on improving its operational efficiency, enhancing revenue streams, and potentially attracting more institutional investors to bolster its market position. The combination of strong promoter confidence and recent financial improvements presents a foundation for potential growth, provided the company can navigate its operational challenges effectively.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Fundviser Capital (India) Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Monarch Networth Capital Ltd | 2,441 Cr. | 308 | 484/280 | 15.7 | 111 | 0.33 % | 33.3 % | 26.2 % | 10.0 |
| Monotype India Ltd | 35.2 Cr. | 0.50 | 2.42/0.46 | 4.87 | 0.03 | 0.00 % | 286 % | % | 1.00 |
| Multipurpose Trading & Agencies Ltd | 4.96 Cr. | 10.0 | 12.6/8.25 | 9.25 | 0.00 % | 3.68 % | 3.38 % | 10.0 | |
| Munoth Financial Services Ltd | 24.8 Cr. | 48.4 | 72.0/47.6 | 19.9 | 0.00 % | 2.41 % | 3.38 % | 10.0 | |
| Naperol Investments Ltd | 466 Cr. | 810 | 1,433/772 | 48.4 | 2,055 | 1.10 % | 1.06 % | 0.95 % | 10.0 |
| Industry Average | 7,061.43 Cr | 1,444.02 | 75.87 | 3,872.22 | 0.35% | 21.83% | 14.30% | 7.26 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.02 | 0.02 | 0.03 | -0.03 | 0.02 | 0.62 | 0.08 | 0.25 | 0.01 | 0.00 | 0.32 | 0.61 | 0.32 |
| Expenses | 0.05 | 0.05 | 0.06 | 0.07 | 0.06 | 0.05 | 0.07 | 0.20 | 0.04 | 0.09 | 0.70 | 0.77 | 0.64 |
| Operating Profit | -0.03 | -0.03 | -0.03 | -0.10 | -0.04 | 0.57 | 0.01 | 0.05 | -0.03 | -0.09 | -0.38 | -0.16 | -0.32 |
| OPM % | -150.00% | -150.00% | -100.00% | -200.00% | 91.94% | 12.50% | 20.00% | -300.00% | -118.75% | -26.23% | -100.00% | ||
| Other Income | 0.01 | 0.02 | 0.15 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 1.10 | 0.12 | 0.20 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| Profit before tax | -0.02 | -0.01 | 0.12 | -0.10 | -0.04 | 0.57 | 0.01 | 0.05 | -0.03 | -0.08 | 0.72 | -0.04 | -0.13 |
| Tax % | 0.00% | 0.00% | 16.67% | -10.00% | -25.00% | 12.28% | 400.00% | 80.00% | -33.33% | -25.00% | 25.00% | -50.00% | 0.00% |
| Net Profit | -0.01 | -0.01 | 0.10 | -0.09 | -0.03 | 0.50 | -0.03 | 0.00 | -0.02 | -0.06 | 0.54 | -0.02 | -0.12 |
| EPS in Rs | -0.03 | -0.03 | 0.27 | -0.24 | -0.08 | 1.36 | -0.08 | 0.00 | -0.04 | -0.13 | 1.05 | -0.04 | -0.20 |
Last Updated: August 19, 2025, 3:10 pm
Below is a detailed analysis of the quarterly data for Fundviser Capital (India) Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 0.32 Cr.. The value appears to be declining and may need further review. It has decreased from 0.61 Cr. (Mar 2025) to 0.32 Cr., marking a decrease of 0.29 Cr..
- For Expenses, as of Jun 2025, the value is 0.64 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.77 Cr. (Mar 2025) to 0.64 Cr., marking a decrease of 0.13 Cr..
- For Operating Profit, as of Jun 2025, the value is -0.32 Cr.. The value appears to be declining and may need further review. It has decreased from -0.16 Cr. (Mar 2025) to -0.32 Cr., marking a decrease of 0.16 Cr..
- For OPM %, as of Jun 2025, the value is -100.00%. The value appears to be declining and may need further review. It has decreased from -26.23% (Mar 2025) to -100.00%, marking a decrease of 73.77%.
- For Other Income, as of Jun 2025, the value is 0.20 Cr.. The value appears strong and on an upward trend. It has increased from 0.12 Cr. (Mar 2025) to 0.20 Cr., marking an increase of 0.08 Cr..
- For Interest, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Depreciation, as of Jun 2025, the value is 0.01 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.00 Cr. (Mar 2025) to 0.01 Cr., marking an increase of 0.01 Cr..
- For Profit before tax, as of Jun 2025, the value is -0.13 Cr.. The value appears to be declining and may need further review. It has decreased from -0.04 Cr. (Mar 2025) to -0.13 Cr., marking a decrease of 0.09 Cr..
- For Tax %, as of Jun 2025, the value is 0.00%. The value appears to be increasing, which may not be favorable. It has increased from -50.00% (Mar 2025) to 0.00%, marking an increase of 50.00%.
- For Net Profit, as of Jun 2025, the value is -0.12 Cr.. The value appears to be declining and may need further review. It has decreased from -0.02 Cr. (Mar 2025) to -0.12 Cr., marking a decrease of 0.10 Cr..
- For EPS in Rs, as of Jun 2025, the value is -0.20. The value appears to be declining and may need further review. It has decreased from -0.04 (Mar 2025) to -0.20, marking a decrease of 0.16.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: November 15, 2025, 3:20 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3.21 | 3.61 | 0.00 | 0.00 | 0.34 | 0.25 | 0.28 | 0.24 | 0.15 | 0.22 | 0.97 | 2.17 | 2.30 |
| Expenses | 3.82 | 3.78 | 1.85 | 0.39 | 0.34 | 0.29 | 0.23 | 0.20 | 0.21 | 0.23 | 0.37 | 1.60 | 2.49 |
| Operating Profit | -0.61 | -0.17 | -1.85 | -0.39 | 0.00 | -0.04 | 0.05 | 0.04 | -0.06 | -0.01 | 0.60 | 0.57 | -0.19 |
| OPM % | -19.00% | -4.71% | 0.00% | -16.00% | 17.86% | 16.67% | -40.00% | -4.55% | 61.86% | 26.27% | -8.26% | ||
| Other Income | 0.17 | 0.23 | 3.27 | 0.49 | 0.00 | 0.13 | 0.01 | 0.60 | 0.05 | 0.00 | 0.00 | 0.00 | 1.42 |
| Interest | 0.02 | 0.03 | 0.00 | 0.06 | 0.02 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.02 |
| Depreciation | 0.30 | 0.68 | 0.01 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.02 |
| Profit before tax | -0.76 | -0.65 | 1.41 | 0.04 | -0.02 | 0.07 | 0.06 | 0.64 | -0.01 | -0.01 | 0.59 | 0.56 | 1.19 |
| Tax % | -5.26% | -24.62% | -8.51% | 25.00% | 50.00% | 0.00% | 66.67% | 17.19% | 200.00% | 0.00% | 25.42% | 23.21% | |
| Net Profit | -0.73 | -0.48 | 1.53 | 0.02 | -0.03 | 0.07 | 0.02 | 0.52 | -0.03 | -0.01 | 0.44 | 0.43 | 0.92 |
| EPS in Rs | -1.98 | -1.30 | 4.15 | 0.05 | -0.08 | 0.19 | 0.05 | 1.41 | -0.08 | -0.03 | 1.19 | 0.83 | 1.69 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 34.25% | 418.75% | -98.69% | -250.00% | 333.33% | -71.43% | 2500.00% | -105.77% | 66.67% | 4500.00% | -2.27% |
| Change in YoY Net Profit Growth (%) | 0.00% | 384.50% | -517.44% | -151.31% | 583.33% | -404.76% | 2571.43% | -2605.77% | 172.44% | 4433.33% | -4502.27% |
Fundviser Capital (India) Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -6% |
| 5 Years: | 47% |
| 3 Years: | 135% |
| TTM: | 30% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 85% |
| 3 Years: | 154% |
| TTM: | -24% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 40% |
| 5 Years: | 100% |
| 3 Years: | 142% |
| 1 Year: | 49% |
| Return on Equity | |
|---|---|
| 10 Years: | 1% |
| 5 Years: | 2% |
| 3 Years: | 3% |
| Last Year: | 3% |
Last Updated: September 5, 2025, 3:30 pm
No data available for the Balance Sheet data table.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 36.39 | 30.33 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 63.97 | 79.06 | ||
| Inventory Days | 65.51 | 11.36 | ||||||||||
| Days Payable | 10.92 | 0.00 | ||||||||||
| Cash Conversion Cycle | 90.98 | 41.69 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 63.97 | 79.06 | ||
| Working Capital Days | 185.34 | 121.33 | -21.47 | 160.60 | 26.07 | 2,843.96 | 97.33 | 49.77 | 989.64 | 518.06 | ||
| ROCE % | -13.70% | -14.81% | -2.01% | 1.70% | 0.67% | -0.17% | 1.04% | 0.99% | -0.16% | -1.42% | 6.09% | 3.76% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 |
|---|---|
| FaceValue | 10.00 |
| Basic EPS (Rs.) | 5.17 |
| Diluted EPS (Rs.) | 4.50 |
| Cash EPS (Rs.) | 5.22 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 36.33 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 36.33 |
| Revenue From Operations / Share (Rs.) | 64.60 |
| PBDIT / Share (Rs.) | 5.79 |
| PBIT / Share (Rs.) | 5.75 |
| PBT / Share (Rs.) | 5.51 |
| Net Profit / Share (Rs.) | 5.17 |
| NP After MI And SOA / Share (Rs.) | 3.07 |
| PBDIT Margin (%) | 8.97 |
| PBIT Margin (%) | 8.89 |
| PBT Margin (%) | 8.53 |
| Net Profit Margin (%) | 8.00 |
| NP After MI And SOA Margin (%) | 4.75 |
| Return on Networth / Equity (%) | 8.45 |
| Return on Capital Employeed (%) | 11.64 |
| Return On Assets (%) | 2.90 |
| Total Debt / Equity (X) | 0.39 |
| Current Ratio (X) | 1.33 |
| Quick Ratio (X) | 1.33 |
| Interest Coverage Ratio (X) | 24.74 |
| Interest Coverage Ratio (Post Tax) (X) | 23.08 |
| Enterprise Value (Cr.) | 87.19 |
| EV / Net Operating Revenue (X) | 2.62 |
| EV / EBITDA (X) | 29.20 |
| MarketCap / Net Operating Revenue (X) | 2.27 |
| Price / BV (X) | 4.04 |
| Price / Net Operating Revenue (X) | 2.27 |
| EarningsYield | 0.02 |
After reviewing the key financial ratios for Fundviser Capital (India) Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. No previous period data is available for comparison.
- For Basic EPS (Rs.), as of Mar 25, the value is 5.17. This value is within the healthy range. No previous period data is available for comparison.
- For Diluted EPS (Rs.), as of Mar 25, the value is 4.50. This value is below the healthy minimum of 5. No previous period data is available for comparison.
- For Cash EPS (Rs.), as of Mar 25, the value is 5.22. This value is within the healthy range. No previous period data is available for comparison.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 36.33. No previous period data is available for comparison.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 36.33. No previous period data is available for comparison.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 64.60. No previous period data is available for comparison.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 5.79. This value is within the healthy range. No previous period data is available for comparison.
- For PBIT / Share (Rs.), as of Mar 25, the value is 5.75. This value is within the healthy range. No previous period data is available for comparison.
- For PBT / Share (Rs.), as of Mar 25, the value is 5.51. This value is within the healthy range. No previous period data is available for comparison.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 5.17. This value is within the healthy range. No previous period data is available for comparison.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 3.07. This value is within the healthy range. No previous period data is available for comparison.
- For PBDIT Margin (%), as of Mar 25, the value is 8.97. This value is below the healthy minimum of 10. No previous period data is available for comparison.
- For PBIT Margin (%), as of Mar 25, the value is 8.89. This value is below the healthy minimum of 10. No previous period data is available for comparison.
- For PBT Margin (%), as of Mar 25, the value is 8.53. This value is below the healthy minimum of 10. No previous period data is available for comparison.
- For Net Profit Margin (%), as of Mar 25, the value is 8.00. This value is within the healthy range. No previous period data is available for comparison.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 4.75. This value is below the healthy minimum of 8. No previous period data is available for comparison.
- For Return on Networth / Equity (%), as of Mar 25, the value is 8.45. This value is below the healthy minimum of 15. No previous period data is available for comparison.
- For Return on Capital Employeed (%), as of Mar 25, the value is 11.64. This value is within the healthy range. No previous period data is available for comparison.
- For Return On Assets (%), as of Mar 25, the value is 2.90. This value is below the healthy minimum of 5. No previous period data is available for comparison.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.39. This value is within the healthy range. No previous period data is available for comparison.
- For Current Ratio (X), as of Mar 25, the value is 1.33. This value is below the healthy minimum of 1.5. No previous period data is available for comparison.
- For Quick Ratio (X), as of Mar 25, the value is 1.33. This value is within the healthy range. No previous period data is available for comparison.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 24.74. This value is within the healthy range. No previous period data is available for comparison.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 23.08. This value is within the healthy range. No previous period data is available for comparison.
- For Enterprise Value (Cr.), as of Mar 25, the value is 87.19. No previous period data is available for comparison.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.62. This value is within the healthy range. No previous period data is available for comparison.
- For EV / EBITDA (X), as of Mar 25, the value is 29.20. This value exceeds the healthy maximum of 15. No previous period data is available for comparison.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.27. This value is within the healthy range. No previous period data is available for comparison.
- For Price / BV (X), as of Mar 25, the value is 4.04. This value exceeds the healthy maximum of 3. No previous period data is available for comparison.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.27. This value is within the healthy range. No previous period data is available for comparison.
- For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. No previous period data is available for comparison.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Unable to fetch valid data for stock valuation.Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Fundviser Capital (India) Ltd:
- Net Profit Margin: 8%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 11.64% (Industry Average ROCE: 21.83%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 8.45% (Industry Average ROE: 14.3%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 23.08
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.33
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 133 (Industry average Stock P/E: 75.87)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.39
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 8%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Finance & Investments | 22, 7th Floor, Manek Mahal, Next to Ambassador Hotel, Mumbai Maharashtra 400020 | info@fundvisercapital.in http://www.fundvisercapital.in |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Prem Krishan Jain | Chairman & Managing Director |
| Mrs. Kriti Jain | Whole Time Director |
| Mr. Triloki Nath Bansal | Independent Director |
| Mr. Vinodkumar Singh | Independent Director |
| Mr. Suresh Kumar Jain | Independent Director |